NCT00488449View on ClinicalTrials.gov

Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Healthy SubjectsDyslipidaemias

Interventions

DRUG

GSK256073A tablets

Trial Locations (1)

21225

GSK Investigational Site, Baltimore

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY